Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
10 drugs in development
By Therapeutic Area
top 6
R&D Momentum
80/100
Pipeline Velocity
49/100
Trial Completion Rate
73/100
Pipeline Concentration
15/100
Pipeline Freshness
62/100
Strategic Signals
Activity
Last 14 days
Effect of External Pressure and Muscle Contraction on Soft Tissue Oxygenation Measured With Functional MRI
Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach
Deucravacitinib in the Treatment of Cicatricial Alopecias
A Pilot Study to Assess Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
A Randomized Trial of Perception of Airflow Limitation Training to Improve Outcomes for Older Adults With Asthma
Pregnancy and Postpartum Continuous Glucose Monitoring in Gestational Diabetes
A Randomized Controlled Trial of Transcutaneous Electrical Nerve Stimulation (TENS) for Treatment of IUD Insertion Pain
The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults: A Pilot Behavioral Study
Erector Spinae Plane Block vs. Pecto-intercostal Fascial Plane Block vs. Control for Sternotomy: A Prospective Randomized Trial
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)